Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates

Background: Patent ductus arteriosus (PDA) is a common cause of morbidity in premature neonates. The purpose of this study was to compare the efficacy of oral ibuprofen and oral acetaminophen to closure of symptomatic PDA, in premature neonates with gestational age (GA) ≤32 weeks. Materials and Meth...

Full description

Bibliographic Details
Main Authors: Mehdi Ghaderian, Behzad Barekatain, Amir Banazade Dardashty
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=96;epage=96;aulast=Ghaderian
_version_ 1818029114111557632
author Mehdi Ghaderian
Behzad Barekatain
Amir Banazade Dardashty
author_facet Mehdi Ghaderian
Behzad Barekatain
Amir Banazade Dardashty
author_sort Mehdi Ghaderian
collection DOAJ
description Background: Patent ductus arteriosus (PDA) is a common cause of morbidity in premature neonates. The purpose of this study was to compare the efficacy of oral ibuprofen and oral acetaminophen to closure of symptomatic PDA, in premature neonates with gestational age (GA) ≤32 weeks. Materials and Methods: This study was a randomized clinical trial with forty preterm neonates who were admitted in neonatal intensive care unit with symptomatic PDA and GA ≤32 weeks or birth body weight ≤1500 g. Twenty neonates received oral acetaminophen [Group A] and twenty neonates received oral ibuprofen [Group B] and compared with echocardiography finding each groups for closed PDA before and after treatment regiment. Results: Our results showed that the primary closure rate of PDA was 70% (95% confidence interval [CI]: 49.9%–90%) and 65% (95% CI: 54.3%–75.7%) in the acetaminophen and ibuprofen groups, respectively, and statistically no significant difference was observed between the two groups (P = 0.74). Conclusion: These findings suggest that there was no significant difference between the effectiveness of oral acetaminophen and oral ibuprofen on closing of PDA, but less adverse effects and contraindication for acetaminophen make it reasonable choice for the treatment of symptomatic PDA.
first_indexed 2024-12-10T05:14:32Z
format Article
id doaj.art-9a8ec64462dd46a1a04cae0f7c170a18
institution Directory Open Access Journal
issn 1735-1995
1735-7136
language English
last_indexed 2024-12-10T05:14:32Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Medical Sciences
spelling doaj.art-9a8ec64462dd46a1a04cae0f7c170a182022-12-22T02:01:00ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362019-01-01241969610.4103/jrms.JRMS_197_19Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonatesMehdi GhaderianBehzad BarekatainAmir Banazade DardashtyBackground: Patent ductus arteriosus (PDA) is a common cause of morbidity in premature neonates. The purpose of this study was to compare the efficacy of oral ibuprofen and oral acetaminophen to closure of symptomatic PDA, in premature neonates with gestational age (GA) ≤32 weeks. Materials and Methods: This study was a randomized clinical trial with forty preterm neonates who were admitted in neonatal intensive care unit with symptomatic PDA and GA ≤32 weeks or birth body weight ≤1500 g. Twenty neonates received oral acetaminophen [Group A] and twenty neonates received oral ibuprofen [Group B] and compared with echocardiography finding each groups for closed PDA before and after treatment regiment. Results: Our results showed that the primary closure rate of PDA was 70% (95% confidence interval [CI]: 49.9%–90%) and 65% (95% CI: 54.3%–75.7%) in the acetaminophen and ibuprofen groups, respectively, and statistically no significant difference was observed between the two groups (P = 0.74). Conclusion: These findings suggest that there was no significant difference between the effectiveness of oral acetaminophen and oral ibuprofen on closing of PDA, but less adverse effects and contraindication for acetaminophen make it reasonable choice for the treatment of symptomatic PDA.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=96;epage=96;aulast=Ghaderianacetaminophenibuprofenpatent ductus arteriosus
spellingShingle Mehdi Ghaderian
Behzad Barekatain
Amir Banazade Dardashty
Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
Journal of Research in Medical Sciences
acetaminophen
ibuprofen
patent ductus arteriosus
title Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
title_full Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
title_fullStr Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
title_full_unstemmed Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
title_short Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
title_sort comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
topic acetaminophen
ibuprofen
patent ductus arteriosus
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2019;volume=24;issue=1;spage=96;epage=96;aulast=Ghaderian
work_keys_str_mv AT mehdighaderian comparisonoforalacetaminophenwithoralibuprofenonclosureofsymptomaticpatentductusarteriosusinpretermneonates
AT behzadbarekatain comparisonoforalacetaminophenwithoralibuprofenonclosureofsymptomaticpatentductusarteriosusinpretermneonates
AT amirbanazadedardashty comparisonoforalacetaminophenwithoralibuprofenonclosureofsymptomaticpatentductusarteriosusinpretermneonates